Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs (NCT06014619) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
Netherlands500 participantsStarted 2023-08-01
Plain-language summary
Mohs micro-graphic surgery (Mohs) is a tissue-sparing, surgical treatment for different types of skin cancer (e.g. basal cell carcinoma, squamous cell carcinoma, lentigo maligna (melanoma). It is a procedure performed with frozen sections. Slow Mohs, a variant of micro-graphic surgery, is performed by formalin fixation and paraffin-embedded sections. Both in Mohs and Slow Mohs tumor margins are assessed to achieve complete removal. This study aims to investigate the clinical presentation and outcomes (i.e. complications and recurrence rates) in patients treated with Mohs or Slow Mohs in the dermatology department of the Maastricht University Medical Center+ in Maastricht, the Netherlands.
Who can participate
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patients with a cutaneous lesion with an indication for Mohs micrographic surgery or Slow Mohs
* patients who received a treatment with either Mohs or Slow Mohs between 1 july 2017 and 1 july 2023 at the dermatology department of the Maastricht University Medical Center+.
Exclusion Criteria:
* None.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is tracking complications and recurrences after Mohs surgery and Slow Mohs — given my specific diagnosis, whether that's basal cell carcinoma, squamous cell carcinoma, lentigo maligna, or another type, which of these two surgical approaches would my care team most likely recommend for me, and why?
2Since this trial is listed as 'active but no longer recruiting,' does that mean any data or early findings are already influencing how your practice handles post-surgical follow-up for complications or recurrence after Mohs procedures?
3The study is measuring how often complications and recurrences happen after these surgeries — what are the most common complications I should watch for after Mohs or Slow Mohs surgery, and how soon after the procedure would a recurrence typically become detectable?
4For my particular type of skin cancer and its location on my body, is standard Mohs micrographic surgery or the Slow Mohs technique considered the better option, and are there non-surgical alternatives we should discuss before committing to either?
5Since this is a Phase NA observational-style study focused on outcomes rather than testing a new treatment, does participating in or being treated at a center involved in this kind of research typically affect how closely patients are monitored for recurrence compared to routine care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of complications
Timeframe: Within 1 month after completion of the surgical intervention.
2
Incidence of recurrence
Timeframe: Up to 5 year after completion of the surgical intervention.